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Abstract 
We compared the blood RNA transcriptome of children hospitalised with influenza A H1N1/09, 
RSV or bacterial infection, and healthy controls. Compared to controls, H1N1/09 patients 
showed increased expression of inflammatory pathway genes, and reduced expression of 
adaptive immune pathway genes. This was validated on an independent cohort. The most 
significant function distinguishing H1N1/09 patients from controls was protein synthesis, with 
reduced gene expression. Reduced expression of protein synthesis genes also characterised 
the H1N1/09 expression profile compared to children with RSV and bacterial infection, 
suggesting that this is a key component of the pathophysiological response in children 
hospitalised with H1N1/09 infection. 
 
Key Words (MeSH): influenza; respiratory tract infection; gene expression profiling; RSV; 
Peptide Chain Initiation, Translational; eIF-2 Kinase; microarray analysis; pediatric
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Introduction 
Whilst children with H1N1/09 influenza A (H1N1/09) commonly had a mild illness, a proportion 
requiring intensive care developed cardiovascular shock, multi-organ failure and fatal disease 
[1]. UK paediatric mortality rates for H1N1/09 were 5–11 per million [2], the highest since 2004, 
when meningococcal serogroup C vaccine was introduced. 
 
Whole blood RNA expression profiling is ideally suited to study emerging infections as it allows 
interrogation of the host response [3]. Influenza studies have included the immunopathogenesis 
of in vivo experimental challenge [4], in addition to in vitro infection and vaccination models. 
Published whole blood transcription data from H1N1/09-infected patients has focussed on 
adults, whose immune response is influenced by recall from previous influenza infection [5, 6]. 
We postulated that comparison of RNA expression in patients with H1N1/09 with other common 
childhood infections would reveal key immunopathogenic responses to the pandemic agent. 
We studied RNA expression profiles in whole blood of prospectively recruited children 
hospitalised with respiratory infections during 2009/10, as the H1N1/09 pandemic evolved in 
the UK.  
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Methods 
Patient Cohorts 
Between July 2009 and June 2010, we recruited 165 acutely ill febrile children (below 17 years) 
with respiratory infection of sufficient severity to warrant blood tests, at St Mary’s Hospital 
London. Whole blood for RNA was collected in PAXgene® tubes, together with clinical samples, 
including a full blood count which was analysed in the hospital laboratory. Cases were recruited 
early in their hospital assessment, before diagnostic studies were completed, and were 
assigned to diagnostic categories once results were available (Supplementary Figure 1). The 
study had approval of the St Mary’s Research Ethics Committee (REC 09/H0712/58). Written, 
informed consent was obtained.  
 
Pathogen diagnosis 
Viral diagnostic studies were undertaken on nasopharyngeal aspirates using 
immunofluorescence (RSV, adenovirus, parainfluenza virus, influenza A+B) and nested PCR 
(RSV, coronavirus, adenovirus, parainfluenza 1-4, influenza A+B, bocavirus, metapneumovirus, 
rhinovirus). Bacterial diagnostics included culture of blood and pleural fluid, and pneumococcal 
antigen detection in blood or urine where available.  
 
RNA expression profiling:  
PAXgene® tubes were extracted using PAXgene Blood RNA extraction kits (Qiagen) according 
to the manufacturer’s instructions. After quantification and quality control, biotin-labelled cRNA 
was prepared from 330ng mRNA using Illumina TotalPrep RNA Amplification kits (Applied 
Biosystems). 750ng labelled cRNA was hybridised to Illumina HumanHT-12 v3 Expression 
BeadChips, and the microarrays scanned. Quality control parameters were assessed using 
Genome Studio software, visual inspection of the microarray images and Principal Component 
Analysis (PCA). PCA was used to identify significant influences on the data other than disease 
cohort, such as technical factors, comorbidities or concurrent medications. One RSV patient 
with poor quality array data was removed. Two children in the H1N1, RSV and bacterial cohorts 
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had oral or intravenous steroids prior to blood sampling, but none were found to be outliers 
from their cohorts using PCA or unsupervised clustering algorithms (data not shown).  
 
Microarray Analysis 
Expression data were analysed using ‘R’ Language and Environment for Statistical Computing 
2.12.1 and GeneSpringGX 11.5 software (Agilent). Additional detail is provided online 
(Supplementary Methods). The data have been deposited in NCBI's Gene Expression Omnibus 
[7] and are accessible through Series accession number GSE42026 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE42026).  
 
Pathway analysis 
Data were analysed using IPA (Ingenuity® Systems, www.ingenuity.com). We filtered the 
datasets, ranked by P-value, to a limit of 800 network-associated molecules, to identify the 
strongest biological signals. We identified the pathways from the IPA library of canonical 
pathways that were most significantly represented in our dataset.  
 
Statistical analysis of cohorts 
Differences between cohorts in age, proportion of white cell type and days from illness onset to 
presentation were calculated using Kruskall-Wallis tests, with Dunn’s post-test comparisons of 
each cohort (Graphpad Prism). Differences in gender, severity of illness and deaths were 
calculated using chi-squared tests of independence (Supplementary Table 1).  
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Results 
We recruited febrile children hospitalised for respiratory illness, including 25 patients with 
H1N1/09 infection (6 co-infected with other pathogens), 34 with respiratory syncytial virus 
(RSV) infection (11 co-infected), and 18 with gram-positive bacterial infection (Supplementary 
Figure 1). Thirty-three healthy control children were recruited from the outpatients department. 
Patient demographic and clinical data are summarised in Supplementary Table 1.  
 
RNA expression 
RNA expression profiling was undertaken on venous blood. Comparing children with H1N1/09 
infection and controls, we found 1,267 significantly differentially expressed (SDE) transcripts 
(P<0.001) (Supplementary Data S1, S2a). Unsupervised clustering analysis separated the 
subjects into distinct highly concordant groups (Figure 1a). When the transcript set was tested 
using Support Vector Machine (SVM) with leave-one-out validation, strong class prediction 
sensitivity was achieved (96%) (Supplementary Data S1). 
 
When the two other infection cohorts (RSV and bacterial infection) were compared to controls, 
we identified 1,172 and 1,869 SDE transcripts (P<0.001) respectively (Supplementary Data S1, 
S2b,c). The validity of these transcript sets in distinguishing each infection from controls was 
analysed by SVM giving a sensitivity of 95% and 98% for RSV- and bacterial-infected patients 
respectively) (Supplementary Data S1). As the RSV cohort was, as expected, significantly 
younger than the control or H1N1 cohorts, we investigated the effect of age on gene expression 
by comparing the RSV patients to a subgroup of the youngest controls (n=10, median age 9 
months). There were 2,411 SDE genes (corrected P<0.05). These showed strong concordance 
with the SDE genes in the RSV vs. all controls comparison: 772 of the top 800 SDE transcripts 
between RSV and youngest controls had the same direction of expression in both datasets; 28 
transcripts were not represented in the comparator dataset.  
 
 Gene expression profile of influenza H1N1 
  Page 8 of 27 
Identification of biological processes in H1N1/09 and comparator infections 
The biological significance of the transcript sets distinguishing H1N1/09, RSV, and bacterial 
infections from controls was investigated with IPA (Ingenuity® Systems, www.ingenuity.com), 
which assigns SDE transcripts to known biological functions and pathways. Biological functions 
matched by the SDE genes for all 3 comparisons were enriched for infectious disease, 
respiratory disease and inflammatory response genes (Supplementary Data S3).  
 
In the H1N1/09 vs. controls dataset, the functional category “protein synthesis” was significantly 
overrepresented (P=7.93x10-26). Furthermore, the 3 most significant canonical pathways in this 
dataset were related to the initiation of protein translation: eukaryotic initiation factor 2 (eIF2 - 
P=3.16x10-25), eukaryotic initiation factor 4 (eIF4 - P=3.24x10-88) and mammalian target of 
rapamycin (mTOR - P=1.91x10-6) (Supplementary Data S4).  
 
When transcripts with increased or decreased abundance were examined separately, those 
with increased abundance were enriched for immune response pathways and functions, 
including signalling from pattern recognition receptors (top increased genes OAS3, C1QB, C1QC), 
interferon signalling (IFI35, IFIT1, IFT3), and antigen presentation through MHC class I (TAP1, 
MR1, HLA-B). Transcripts with reduced abundance were enriched for pathways including 
antigen presentation through MHC class II (most decreased: HLA-DQA, HLA-DPB, HLA-DOA), T 
cell signalling and protein synthesis - including those involved in translation, elongation and 
ribosomal transport (Supplementary Data S4). There was reduced expression in 63 of 69 SDE 
transcripts in the eIF2 pathway, P<0.0001. Protein synthesis-related transcripts with increased 
expression included genes with known inhibitory functions in protein synthesis, including 
EIF2AK2, IFIT1/ISG56 and IFIT2/ISG54 (fold change (FC) of 15.3, 1013 and 16.2 respectively 
in H1N1/09 relative to controls) [8, 9].  
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Comparison to an independent validation dataset 
In order to validate our findings, we used a publically available adult dataset for H1N1/09 and 
controls [6]. There was complete segregation of H1N1/09 patients and controls when SDE 
transcripts from our data were used for clustering (Supplementary  Figure 2a). We used the 
SVM prediction model trained on our H1N1/09 vs. control data and applied this to the 
independent dataset, there was 100% sensitivity and specificity of disease and control status. 
We investigated whether the 69 represented transcripts in the top canonical pathway, EIF2 
signalling, were significantly differentially expressed in the validation dataset. 32 were SDE in 
the adult study, including 31 with the same direction of regulation (Supplementary Figure 2b).  
 
Comparison of the H1N1/09 host response with RSV and bacterial infection 
Having identified the expression profile distinguishing patients with each pathogen infection 
from healthy children, we compared the response to H1N1/09 with RSV and bacterial infection 
in order to identify unique aspects of the transcription profile of H1N1/09 infection. Transcripts 
that were SDE between H1N1/09 and RSV (n=601 of 7,295 transcripts, corrected P<0.01) and 
between H1N1/09 and bacterial infection (n=734 of 6,808 transcripts, corrected P<0.01) were 
used for unsupervised clustering and for classification, H1N1/09 cases were distinguished from 
RSV cases (Figure 1b) and bacterial cases (Figure 1c) with accuracy of 93% for H1N1/09 vs. 
RSV and 92% for H1N1/09 vs. bacteria (Supplementary Data S1, S2d,e). 
 
‘Protein synthesis’ was the most significant functional category in both the H1N1/09 vs. RSV, 
and H1N1/09 vs. bacterial infection datasets (corrected P=2.73x10-13 and 1.6x10-11 
respectively). The most significant canonical pathways related to protein synthesis - the eIF2 
pathway (P=2.0 x 10-20 and 9.0 x 10-10); eIF4 (P=4.7 x 10-8-x and 0.006) and mTOR (P=8.1 x 10-
7 and 0.016) for H1N1/09 vs. RSV, and H1N1/09 vs. bacterial infection respectively (Figure 2 
and Supplementary Data S3, S4). 
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Discussion 
Whole blood RNA expression profiling demonstrated marked differences in transcriptional 
profiles in H1N1/09-infected patients compared to controls or to RSV and gram-positive 
bacterial infection. In relation to controls, H1N1/09 patients showed increased expression in 
well-established pathways of the innate antiviral immune response, including pattern 
recognition receptor, interferon signalling and myeloid cell activation pathways. Many 
interferon-induced genes with antiviral roles showed increased differential expression, including 
IFI27 (P=5.8x10-11, FC 5.8x1021), and genes implicated in repression of protein synthesis 
including EIF2AK2, and also IFIT1 and IFIT2, whose antiviral roles may be mediated through 
effects on translation [10, 11]. Recent work in humans and mice has implicated the interferon-
induced IFITM3 gene in restricting influenza A infection [12]. Our finding of strongly increased 
IFITM3 expression (P=3x10-3, FC 76.2) supports its role in H1N1/09 infection.  
 
Differences in whole blood gene expression between cohorts can reflect altered proportions of 
cell types and/or altered transcript abundance within cell types. We used concurrent clinical full 
blood count data to compare lymphocyte proportions in each cohort (Supplementary Table 1). 
Lymphocyte proportion differed significantly only between H1N1/09 and controls (ratio 2.1:1). 
By comparison, the fold change between cohorts was higher in all 800 transcripts used for 
Ingenuity analysis (range 2.3-5x1021, median 4.5). This indicates that differences in lymphocyte 
proportion are not the major determinants of gene expression level. This does not exclude a 
role for lymphocyte subset populations.  
 
Whilst H1N1/09 patients showed strongly increased expression of innate immune genes, there 
was reduced expression in many adaptive immune response pathways, including T cell 
activation through NFAT, B cell activation and MHC class II antigen presentation. Reduced 
expression of adaptive T and B cell pathways may represent a host negative regulatory 
feedback mechanism [5], or viral-induced immune subversion [13], analogous to viral inhibition 
of antigen presentation by inhibition of the MHC class II transactivator.  
 Gene expression profile of influenza H1N1 
  Page 11 of 27 
 
We found that the 3 most significant pathways in our dataset were involved in protein synthesis 
and translation initiation (eIF2, eIF4 and mTOR), and that within these the majority of genes 
showed reduced expression. In contrast, inhibitors of translation including EIF2AK2 (which 
encodes PKR) were upregulated. PKR, when bound to viral double-stranded RNA, 
phosphorylates eukaryotic initiation factor 2 alpha (eIF2a) to cause the arrest of translation 
initiation [14]. This suggests that protein synthesis in H1N1/09 patients may be impaired by 
repressed transcription of genes required for the translation apparatus, and by increased 
transcription of inhibitors of translation. The reduced expression of genes involved in protein 
synthesis was highly significant between H1N1/09 and controls (P=7.9x10-26) and also between 
H1N1/09 and RSV or bacterial infection (P=2.73x10-13 and 1.6x10-11 respectively) (Figure 2). In 
an influenza A challenge study of healthy adult volunteers, differential expression of translation 
initiation pathway genes was identified in symptomatic but not subclinical infections [4], 
supporting a role for altered protein synthesis as a key component of the host response to 
H1N1/09 infection.  
 
Increased expression of protein synthesis-inhibiting genes with reduced expression of 
translation initiation genes is likely to impair protein synthesis. Influenza virus has been 
observed to shut-off protein synthesis and decrease mRNA levels in infected cells [15], but the 
phenomenon we have observed in peripheral blood suggests a widespread alteration affecting 
cells distant from the site of infection in the airway. We therefore hypothesize that suppression 
of protein synthesis may be a distinctive feature of H1N1/09 infection, and may play a role in 
the prolonged debility, fatigue and delayed recovery seen in severely affected patients. Many of 
the fatal cases of respiratory failure in H1N1/09 infection had an unusual illness with prolonged 
Acute Respiratory Distress syndrome, requiring prolonged ventilation [1], and late pulmonary 
haemorrhage or persistent respiratory failure causing death weeks after the acute illness. 
Supressed protein synthesis might result in poor tissue recovery, and may provide an 
explanation for the prolonged illness and poor outcome in some patients.  
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In a neonatal pig model of critical care myopathy, impairment of protein synthesis in association 
with sepsis was mediated through inhibition of mTOR and eIF2 pathways [16]. In vitro infection 
studies using H5N1 influenza virus indicate that impaired mTOR signalling leads to autophagic 
cell death [17]. Further studies are required to confirm that the changes we observed in 
peripheral blood RNA expression for these pathways do represent inhibition of protein 
synthesis, and to confirm the role of this phenomenon in severe illness. 
 
It is unclear whether the changes in expression of genes involved in protein synthesis we have 
observed in peripheral blood are triggered by the virus, or by host mediators released during 
the immune response. Influenza infection is largely confined to epithelial surfaces in the lung, 
and viraemia is infrequent, though more common in severe infection. Changes in the peripheral 
blood may reflect a response to entrance of virus or viral components into the blood, or an 
indirect effect of local cellular activation by host inflammatory molecules. Potentially, there are 
advantages to both the virus and the host in switching off protein synthesis – for instance viral 
immune subversion by impairing leukocyte function, or limitation of production of viral proteins.  
 
Limitations 
Limitations in this study include the younger age of the RSV cohort. The highly varied ethnicity 
of children attending our hospital meant it was not possible to match ethnicities between groups. 
We used a whole-blood gene expression approach: changes in expression during disease 
result from both shifting cell type proportions and upregulation or downregulation of genes 
within cells. The association of influenza with bacterial infection is well known, and occult 
bacterial infection may have contributed to disease in some patients. 
 
In conclusion, our comparative study of RNA expression in children with H1N1/09 infection has 
provided new evidence on the host response to the pandemic strain. The finding that changes 
in expression of genes involved in protein synthesis are a key feature distinguishing H1N1/09 
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from other common childhood infections provides a new avenue for investigating the 
immunopathogenesis of influenza.  
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Figures  
Figure 1. Unsupervised clustering of the top SDE transcripts for a) H1N1/09 and controls, b) 
H1N1/09 and RSV and c) H1N1/09 and bacterial infection 
 
Heatmaps show separation of H1N1/09 and comparator groups by unsupervised Manhattan 
clustering, based on top SDE transcripts. Each row represents one transcript; each column 
represents one patient, with a red bar below indicating H1N1/09 and a blue bar a control (a), 
RSV (b), or bacterial infection (c). Curtailed transcript lists of highly significant probes were 
used for clarity (p value thresholds of 10-5 (n=90 transcripts), 0.002 (n=97) and 0.001 (n=156) 
respectively for control, RSV and bacterial comparisons). Expression intensity is indicated by 
colour (increased abundance in red, decreased in blue, intermediate in yellow). 
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Figure 2. Top Canonical pathways differing between H1N1/09 and controls, RSV and bacterial 
infection  
 
Each bar is coloured in proportion to the number of SDE H1N1/09 transcripts increased (red) or 
decreased (green) in abundance relative to the comparator cohort. The total bar length is 
proportional to P value. Coloured blocks next to each pathway are coded according to 
biological function. Protein synthesis pathways (yellow) were the most significant in all 3 
comparisons, with predominant decreased expression in H1N1/09 patients relative to the 
comparator group. Innate immune pathway transcripts (brown) were increased in H1N1/09 
patients, whilst adaptive immune transcripts (pink) were reduced relative to controls. 
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Supplementary Table 1 - Demographic and clinical data of recruited subjects 
 H1N1/09 RSV Bacterial Controls P value  
Number of patients 25 (+2a) 34 (+2a) 18 33 N/A 
No co-infection 
Co-infection 
 Bocavirus 
 Rhinovirus 
 Adenovirus 
 Seasonal flu 
 parainfluenza 
 Metapneumovirus 
 RSV 
 H1N1/09 
S.pneumoniae 
S.pyogenes 
S.aureus 
19 
6c  
 5 
 2 
 0 
 0 
 0 
 0 
 (+1 a)  
N/A 
 (+1 a)  
 0 
 0 
23 
11c  
 5 
 4 
 2 
 1 
 0 
 0 
N/A 
 0 
 (+2 a) 
 0 
 0 
13b 
5 
 0 
 0 
 1 
 1 
 1 
 2 
 N/A 
 N/A 
12 
4 
2 
N/A  
Sex M:F (% male) 12:13 (48) 21:13 (62) 8:13 (38) 18:15 (55) NS 
Age (years): median (IQR)  4.0 (1.6-7.5) 0.4 (0.1-1.4) 1.9 (1.0-4.4) 3.4 (1.5-6.9) P<0.0001 
Ethnicity- Caucasian (%)  15 (53) 19 (52)  10 (55) 16 (48) NS 
No. additional ethnic groups    7 8 7 8 NS 
Days from symptoms to 
recruitment: median (IQR)  
5 (3.0-7.0) 4 (2.0-6.3) 3.5 (2.0-
10.5) 
N/A NS 
Intensive care required 12 of 25 
(48%) 
20 of 34 
(59%) 
15 of 18 
(83%) 
n/a NS 
Deaths 5 0 1 N/A NS  
Pathogen cohort for arrays 19 (without 
co-infection) 
22d (without 
co-infection) 
18 
(excludes 
H1N1, RSV) 
33 N/A 
Lymphocyte proportion (array 
patients): median (IQR) 
0.21 (0.10-
0.32) 
0.39 (0.28-
0.49) 
0.17 (0.08-
0.25) 
0.45 (0.38-
0.56) 
P<0.001 for 
HvsC 
Neutrophil proportion (array 
patients): median (IQR) 
0.69 (0.52-
0.84) 
0.47 (0.40-
0.64) 
0.74 (0.64-
0.87) 
0.45 (0.35-
0.51) 
P<0.001 for 
HvsC 
Monocyte proportion (array 
patients): median (IQR) 
0.04 (0.01-
0.08) 
0.09 (0.03-
0.15) 
0.03 (0.0-
0.08) 
0.07 (0.06-
0.09) 
NS 
 
NS - not significant (corrected P<0.05); IQR – interquartile range; N/A - not applicable.  
a Two patients each in the H1N1/09 and RSV cohorts with confounding coinfections (RSV or bacterial) 
were excluded from array analysis and from demographic calculations.  
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bAfter excluding patients with H1N1/09 or RSV, patients with confirmed gram-positive bacterial infection 
were analysed irrespective of other viral coinfection - no virological investigations were available for 9 
bacterial infection patients recruited outside the pandemic period.  
cNote that one patient each with RSV and H1N1/09 had two viral coinfections  
dOne RSV patient was excluded as the array data did not pass QC on PCA plot 
The gender distribution between cohorts was not different. The ages of the H1N1/09, bacterial and 
control cohorts were not significantly different. The RSV cohort was younger, as expected for RSV 
bronchiolitis admissions. Days from symptom onset to recruitment, and deaths in each cohort were not 
significantly different. Lymphocyte proportion was lower, and neutrophil proportion higher (denominator 
total leucocytes) in H1N1/09 patients than controls, but was not significantly different when compared to 
the RSV or bacterial groups. 
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Supplementary Figure 1. Study overview showing patient numbers and analysis 
Children with acute infection, sick enough to warrant blood tests, were recruited as early as 
possible at or after presentation. Respiratory or nasopharyngeal secretions were screened for 
viruses as part of routine clinical care, before we used the samples for additional viral detection. 
Patients were assigned to pathogen cohorts on the basis of microbiology results and a 
compatible clinical syndrome. Controls were recruited in out-patients. They had no recent 
(previous two weeks) or current infectious symptoms (for instance coryza), nor had any 
identified or suspected chronic infectious or inflammatory conditions, nor recent immunisation. 
Children with co-morbidities likely to have a profound impact on gene expression were 
excluded, including 11 children with either prior bone marrow transplant or on chemotherapy. In 
the pathogen cohorts we included children with or without other comorbidities, with 
neurodisability the most common (2 in RSV and bacterial; 4 in H1N1).   
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Supplementary Figure 2. Validation of H1N1/09 vs control gene expression on an independent 
cohort 
Data from our cohort were compared with the published adult dataset of Parnell et al [6]. (a): 
Heatmap showing full segregation of adult H1N1/09 patients and controls by unsupervised 
Manhattan clustering in the validation dataset, using the top 90 strongest classifiers derived 
from the 1,267 transcript set defining H1N1/09 vs controls in our own cohort. Each row 
represents one transcript; each column represents one patient, with a red bar below indicating 
H1N1/09 and a blue bar a control. Expression intensity is indicated by colour (increased 
abundance in red, decreased in blue, intermediate in yellow). There was also fully concordant 
separation when the full list of 1,267 transcripts was used (data not shown). (b): 32 transcripts 
in the EIF2 signalling canonical pathway were significantly differentially expressed in the 
validation dataset, with strongly correlating fold change and direction of change from controls 
(Spearman r=0.63, P=0.0001). Upregulated transcripts are plotted in the positive quadrant; 
negative regulation is plotted in the negative quadrant. One transcript was not concordant 
(RPL24).  
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Transcriptomic profiling in childhood H1N1/09 influenza reveals reduced expression of 
protein synthesis genes 
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Online data supplement: supplementary methods 
Microarray Analysis 
Expression data were analysed using ‘R’ Language and Environment for Statistical Computing 
2.12.1 [18] and GeneSpringGX 11.5 software (Agilent).  
 
Mean raw intensity values for each probe were corrected for local background intensities, and 
quantile normalised. The dataset was filtered to exclude probes that were flagged as ‘present’ 
on less than 90% of the arrays in at least one group of interest. Expression values were 
transformed to a log2 scale. Principal component analysis was used to review the quality of all 
arrays (one RSV outlier was removed), and to identify significant influences on the data other 
than disease cohort, such as technical factors, comorbidities or concurrent medications. 
 
In order to ensure that analyses carried out using the GeneSpring platform were valid, and due 
to infection type, data were first analysed in R in order to determine the influence of age, 
gender and technical batch on the expression data. These were considered as independent 
factors in a linear regression model. After normalization, batch, age and gender were found to 
have a weak influence on the expression values. Technical batch effects (particularly array 
chip) were detected during unsupervised clustering of unnormalised data, but the experimental 
design mitigated these effects through the randomization of samples at each stage of sample 
processing - RNA extraction, labelling, hybridisation. The raw background-subtracted data were 
therefore normalized for further analysis without further adjustment.  
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The hypothesis that the expression level for each probe differed between comparator patient 
groups was assessed using Welch’s moderated t-test [19]. P values were adjusted using 
Benjamini and Hochberg’s method to control for the false discovery rate [20]. For each 
comparison of interest the most significant probes were selected, based on P value and 
absolute fold-change >2.  
 
We compared each infection cohort to controls to derive a list of significantly DE transcripts for 
each comparison with P<0.05 and log2FC>1 (Supplementary Data S1). When comparing the 
transcriptional response of two infection cohorts, we included the union of DE transcripts 
between healthy controls and either pathogen.  
 
The Support Vector Machine (SVM) method for supervised learning was used to classify 
patients into groups, based on our pre-defined signatures. We applied a linear SVM to define a 
hyperplane in a high-dimensional transformed feature space that maximally discriminated two 
patient groups. We used leave-one-out cross-validation to calculate the classification accuracy.  
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